In Brief: CellPro
This article was originally published in The Gray Sheet
Executive Summary
CellPro: Judge in the U.S. District Court for the District of Delaware calls for a new trial in a patent suit filed against the firm by Baxter Healthcare, Becton Dickinson, and The Johns Hopkins University. In August 1995, a jury found that the claims of patents referenced in the suit were neither valid nor infringed. Plaintiffs in the case allege that CellPro's Ceprate SC stem cell concentration system and Ceprate LC laboratory cell separation system infringe four patents...
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.